NeuroSense Therapeutics Ltd. Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
NeuroSense Therapeutics Ltd. (NRSN) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $1.43 per share for the 12-month period ending 2024-12-31, per its 20-F filed 2025-04-07.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2025-04-07
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month |
|---|---|---|
| 2024-12-31 | $1.43 20-F · filed 2025-04-07 | |
| 2023-12-31 | $0.80 6-K · filed 2024-06-17 | |
| 2023-08-15 | $0.96 6-K · filed 2024-06-17 | |
| 2023-05-30 | $1.53 6-K · filed 2024-06-17 | |
| 2023-03-20 | $1.82 6-K · filed 2024-06-17 | |
| 2022-12-31 | $1.40 6-K · filed 2024-06-17 | |
| 2022-08-31 | $1.99 20-F · filed 2025-04-07 | |
| 2022-07-31 | $2.18 20-F · filed 2025-04-07 | |
| 2022-06-08 | $7.50 6-K · filed 2024-06-17 | |
| 2022-03-31 | $2.18 6-K · filed 2024-06-17 | |
| 2022-03-15 | $1.67 6-K · filed 2024-06-17 | |
| 2022-01-25 | $2.18 6-K · filed 2024-06-17 | |
| 2021-12-31 | $4.33 6-K · filed 2024-06-17 | |
| 2021-12-15 | $1.67 6-K · filed 2024-06-17 | |
| 2021-12-09 | $6.00 6-K · filed 2024-06-17 | |
| 2021-10-31 | $3.51 6-K · filed 2024-06-17 | |
| 2021-08-31 | $5.33 6-K · filed 2024-06-17 | |
| 2021-07-31 | $0.03 6-K · filed 2024-06-17 | |
| 2021-03-31 | $1.67 6-K · filed 2024-06-17 |